Sadna Budhu

8PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Jun 17, 2024
Intermittent MEK Inhibition with GITR Costimulation Rescues T-cell Function for Increased Efficacy with CTLA-4 Blockade in Solid Tumor Models.

Lauren Dong, Hyejin Choi, Sadna Budhu

|Nov 06, 2023
Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib.

Paul B Chapman, Mark Klang, Michael A Postow

|May 23, 2022
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions.

Sara E Schad, Andrew Chow, Levi Mangarin

|Nov 18, 2021
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer.

Aditi Gupta, Sadna Budhu, Kelly Fitzgerald

Pageof 2

Frequent Collaborators

8 joint publications

Taha Merghoub

8 joint publications

Jedd D Wolchok

3 joint publications

Isabell Schulze

3 joint publications

Daniel Hirschhorn